(Q39489796)

12 September 2017

1 reference

title

Defective adenoviruses as novel vaccines for the Flaviviridae (English)

1 reference

12 September 2017

0 references

1 reference

Stephenson J

1

1 reference

12 September 2017

publication date

1 July 1998

1 reference

Clinical and diagnostic virology

12 September 2017

published in

1 reference

12 September 2017

volume

10

1 reference

12 September 2017

issue

2-3

1 reference

12 September 2017

page(s)

187-194

1 reference

Functional diversity of helper T lymphocytes

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900038-5

7 January 2021

Immune responses throughout hepatitis C virus (HCV) infection: HCV from the immune system point of view

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900038-5

7 January 2021

Epidemiology of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900038-5

7 January 2021

Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900038-5

7 January 2021

The NS1 protein of tick-borne encephalitis virus forms multimeric species upon secretion from the host cell

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900038-5

7 January 2021

Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900038-5

7 January 2021

High-level expression of the measles virus nucleocapsid protein by using a replication-deficient adenovirus vector: induction of an MHC-1-restricted CTL response and protection in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900038-5

7 January 2021

Oral or parenteral administration of replication-deficient adenoviruses expressing the measles virus haemagglutinin and fusion proteins: protective immune responses in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900038-5

7 January 2021

Stabilized 17D strain yellow fever vaccine: dose response studies, clinical reactions and effects on hepatic function

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900038-5

7 January 2021

Preparation of a highly purified vaccine against tick-borne encephalitis by continuous flow zonal ultracentrifugation

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900038-5

7 January 2021

Studies of Japanese Encephalitis in China

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900038-5

7 January 2021

Protection elicited by a replication-defective adenovirus vector expressing the tick-borne encephalitis virus non-structural glycoprotein NS1.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900038-5

7 January 2021

The flavivirus nonstructural protein NS3 is a dominant source of cytotoxic T cell peptide determinants

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900038-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900038-5

1 reference

7 January 2021

Yellow fever vaccine. IV. Reactogenicity and antibody response in volunteers inoculated with a vaccine free from contaminating avian leukosis viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900038-5

7 January 2021

Immunological basis for protection in a murine model of tick-borne encephalitis by a recombinant adenovirus carrying the gene encoding the NS1 non-structural protein

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900038-5

7 January 2021

Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900038-5

7 January 2021

Gene therapy and viral vaccination: the interface

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900038-5

7 January 2021

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900038-5

7 January 2021

10.1016/S0928-0197(98)00038-5

Identifiers

DOI

1 reference

12 September 2017

1 reference